![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ROS1 |
Gene summary for ROS1 |
![]() |
Gene information | Species | Human | Gene symbol | ROS1 | Gene ID | 6098 |
Gene name | ROS proto-oncogene 1, receptor tyrosine kinase | |
Gene Alias | MCF3 | |
Cytomap | 6q22.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | P08922 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6098 | ROS1 | P36T-E | Human | Esophagus | ESCC | 7.91e-07 | 2.65e-01 | 0.1187 |
6098 | ROS1 | P49T-E | Human | Esophagus | ESCC | 7.48e-03 | 5.45e-01 | 0.1768 |
6098 | ROS1 | P62T-E | Human | Esophagus | ESCC | 2.57e-02 | 1.28e-01 | 0.1302 |
6098 | ROS1 | P107T-E | Human | Esophagus | ESCC | 3.76e-35 | 9.87e-01 | 0.171 |
6098 | ROS1 | TD9 | Human | Lung | IAC | 2.29e-02 | 4.31e-01 | 0.088 |
6098 | ROS1 | RNA-P10T2-P10T2-1 | Human | Lung | AAH | 7.35e-09 | 1.29e+00 | -0.1271 |
6098 | ROS1 | RNA-P10T2-P10T2-2 | Human | Lung | AAH | 6.28e-12 | 1.42e+00 | -0.1406 |
6098 | ROS1 | RNA-P10T2-P10T2-3 | Human | Lung | AAH | 3.37e-12 | 1.43e+00 | -0.1408 |
6098 | ROS1 | RNA-P10T2-P10T2-4 | Human | Lung | AAH | 1.91e-14 | 1.54e+00 | -0.138 |
6098 | ROS1 | RNA-P17T-P17T-2 | Human | Lung | IAC | 9.92e-05 | 6.11e-01 | 0.3371 |
6098 | ROS1 | RNA-P17T-P17T-4 | Human | Lung | IAC | 1.21e-05 | 5.96e-01 | 0.343 |
6098 | ROS1 | RNA-P17T-P17T-6 | Human | Lung | IAC | 6.46e-04 | 5.65e-01 | 0.3385 |
6098 | ROS1 | RNA-P17T-P17T-8 | Human | Lung | IAC | 3.82e-05 | 4.47e-01 | 0.3329 |
6098 | ROS1 | RNA-P18T-P18T-8 | Human | Lung | IAC | 4.28e-03 | 1.25e+00 | 0.1151 |
6098 | ROS1 | RNA-P23T2-P23T2-1 | Human | Lung | MIAC | 5.56e-05 | 1.32e+00 | -0.037 |
6098 | ROS1 | RNA-P23T2-P23T2-2 | Human | Lung | MIAC | 7.61e-03 | 1.07e+00 | -0.028 |
6098 | ROS1 | RNA-P23T2-P23T2-4 | Human | Lung | MIAC | 1.00e-05 | 1.38e+00 | -0.0272 |
6098 | ROS1 | RNA-P24T2-P24T2-2 | Human | Lung | IAC | 4.40e-04 | 1.38e+00 | 0.0057 |
6098 | ROS1 | RNA-P25T1-P25T1-1 | Human | Lung | AIS | 5.81e-31 | 1.35e+00 | -0.2116 |
6098 | ROS1 | RNA-P25T1-P25T1-2 | Human | Lung | AIS | 7.54e-17 | 1.42e+00 | -0.1941 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0016049110 | Esophagus | ESCC | cell growth | 289/8552 | 482/18723 | 1.29e-10 | 3.77e-09 | 289 |
GO:000155819 | Esophagus | ESCC | regulation of cell growth | 248/8552 | 414/18723 | 2.97e-09 | 6.45e-08 | 248 |
GO:000206420 | Esophagus | ESCC | epithelial cell development | 136/8552 | 220/18723 | 9.50e-07 | 1.21e-05 | 136 |
GO:003367420 | Esophagus | ESCC | positive regulation of kinase activity | 260/8552 | 467/18723 | 7.26e-06 | 7.22e-05 | 260 |
GO:00319294 | Esophagus | ESCC | TOR signaling | 79/8552 | 126/18723 | 8.57e-05 | 6.21e-04 | 79 |
GO:00182124 | Esophagus | ESCC | peptidyl-tyrosine modification | 202/8552 | 378/18723 | 1.34e-03 | 6.39e-03 | 202 |
GO:00320061 | Esophagus | ESCC | regulation of TOR signaling | 63/8552 | 104/18723 | 1.55e-03 | 7.29e-03 | 63 |
GO:00181084 | Esophagus | ESCC | peptidyl-tyrosine phosphorylation | 200/8552 | 375/18723 | 1.60e-03 | 7.45e-03 | 200 |
GO:0002066 | Esophagus | ESCC | columnar/cuboidal epithelial cell development | 29/8552 | 44/18723 | 5.41e-03 | 2.02e-02 | 29 |
GO:00610417 | Liver | NAFLD | regulation of wound healing | 39/1882 | 134/18723 | 5.52e-10 | 1.28e-07 | 39 |
GO:00420607 | Liver | NAFLD | wound healing | 84/1882 | 422/18723 | 6.56e-10 | 1.37e-07 | 84 |
GO:0042730 | Liver | NAFLD | fibrinolysis | 15/1882 | 25/18723 | 1.26e-09 | 2.30e-07 | 15 |
GO:0030195 | Liver | NAFLD | negative regulation of blood coagulation | 21/1882 | 49/18723 | 2.42e-09 | 4.05e-07 | 21 |
GO:1900047 | Liver | NAFLD | negative regulation of hemostasis | 21/1882 | 50/18723 | 3.78e-09 | 5.40e-07 | 21 |
GO:0030193 | Liver | NAFLD | regulation of blood coagulation | 24/1882 | 66/18723 | 9.30e-09 | 1.26e-06 | 24 |
GO:0050819 | Liver | NAFLD | negative regulation of coagulation | 21/1882 | 53/18723 | 1.33e-08 | 1.69e-06 | 21 |
GO:1900046 | Liver | NAFLD | regulation of hemostasis | 24/1882 | 68/18723 | 1.84e-08 | 2.09e-06 | 24 |
GO:0061045 | Liver | NAFLD | negative regulation of wound healing | 26/1882 | 78/18723 | 1.86e-08 | 2.09e-06 | 26 |
GO:19030347 | Liver | NAFLD | regulation of response to wounding | 41/1882 | 167/18723 | 4.70e-08 | 4.58e-06 | 41 |
GO:0050818 | Liver | NAFLD | regulation of coagulation | 24/1882 | 71/18723 | 4.80e-08 | 4.60e-06 | 24 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ROS1 | SNV | Missense_Mutation | novel | c.2008G>A | p.Val670Met | p.V670M | P08922 | protein_coding | tolerated(0.1) | benign(0.003) | TCGA-AZ-6601-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
ROS1 | SNV | Missense_Mutation | novel | c.4177N>T | p.Asp1393Tyr | p.D1393Y | P08922 | protein_coding | deleterious(0.02) | benign(0.133) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
ROS1 | SNV | Missense_Mutation | novel | c.4044N>T | p.Glu1348Asp | p.E1348D | P08922 | protein_coding | tolerated(0.28) | benign(0) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
ROS1 | SNV | Missense_Mutation | novel | c.1283N>T | p.Arg428Ile | p.R428I | P08922 | protein_coding | deleterious(0.01) | benign(0.133) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
ROS1 | SNV | Missense_Mutation | novel | c.935N>G | p.Glu312Gly | p.E312G | P08922 | protein_coding | tolerated(0.46) | possibly_damaging(0.612) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
ROS1 | SNV | Missense_Mutation | c.6551N>A | p.Arg2184Lys | p.R2184K | P08922 | protein_coding | tolerated(0.52) | benign(0.007) | TCGA-CA-6718-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
ROS1 | SNV | Missense_Mutation | c.6313N>G | p.Leu2105Val | p.L2105V | P08922 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
ROS1 | SNV | Missense_Mutation | c.442N>A | p.Val148Met | p.V148M | P08922 | protein_coding | deleterious(0.02) | probably_damaging(0.993) | TCGA-CK-5916-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
ROS1 | SNV | Missense_Mutation | c.1048N>T | p.Ala350Ser | p.A350S | P08922 | protein_coding | tolerated(0.2) | benign(0.011) | TCGA-CM-6165-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ROS1 | SNV | Missense_Mutation | c.143G>A | p.Gly48Asp | p.G48D | P08922 | protein_coding | tolerated(0.16) | benign(0.358) | TCGA-CM-6674-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
6098 | ROS1 | TYROSINE KINASE, CLINICALLY ACTIONABLE, DRUG RESISTANCE, ENZYME, DRUGGABLE GENOME, KINASE, TRANSCRIPTION FACTOR | Imidazo[1,2-b]pyridazine derivative 2 | |||
6098 | ROS1 | TYROSINE KINASE, CLINICALLY ACTIONABLE, DRUG RESISTANCE, ENZYME, DRUGGABLE GENOME, KINASE, TRANSCRIPTION FACTOR | ENTRECTINIB | ENTRECTINIB | 28183697 | |
6098 | ROS1 | TYROSINE KINASE, CLINICALLY ACTIONABLE, DRUG RESISTANCE, ENZYME, DRUGGABLE GENOME, KINASE, TRANSCRIPTION FACTOR | inhibitor | HESPERADIN | HESPERADIN | 19035792 |
6098 | ROS1 | TYROSINE KINASE, CLINICALLY ACTIONABLE, DRUG RESISTANCE, ENZYME, DRUGGABLE GENOME, KINASE, TRANSCRIPTION FACTOR | CRIZOTINIB | CRIZOTINIB | 23724914,25733882,25351743,25688157,26372962 | |
6098 | ROS1 | TYROSINE KINASE, CLINICALLY ACTIONABLE, DRUG RESISTANCE, ENZYME, DRUGGABLE GENOME, KINASE, TRANSCRIPTION FACTOR | AZD3463 | 26372962 | ||
6098 | ROS1 | TYROSINE KINASE, CLINICALLY ACTIONABLE, DRUG RESISTANCE, ENZYME, DRUGGABLE GENOME, KINASE, TRANSCRIPTION FACTOR | TPX-0005 | |||
6098 | ROS1 | TYROSINE KINASE, CLINICALLY ACTIONABLE, DRUG RESISTANCE, ENZYME, DRUGGABLE GENOME, KINASE, TRANSCRIPTION FACTOR | inhibitor | CRIZOTINIB | CRIZOTINIB | |
6098 | ROS1 | TYROSINE KINASE, CLINICALLY ACTIONABLE, DRUG RESISTANCE, ENZYME, DRUGGABLE GENOME, KINASE, TRANSCRIPTION FACTOR | DS6051b | |||
6098 | ROS1 | TYROSINE KINASE, CLINICALLY ACTIONABLE, DRUG RESISTANCE, ENZYME, DRUGGABLE GENOME, KINASE, TRANSCRIPTION FACTOR | CYC-116 | CYC-116 | ||
6098 | ROS1 | TYROSINE KINASE, CLINICALLY ACTIONABLE, DRUG RESISTANCE, ENZYME, DRUGGABLE GENOME, KINASE, TRANSCRIPTION FACTOR | CRIZOTINIB | CRIZOTINIB | 29596029,23724914,25264305,24875859,25922291,22215748,25688157,26372962,25667280,30980071,29333528 |
Page: 1 2 3 4 5 6 7 |